Construction of recombinant marek's disease virus (rMDV) co-expressing AIV-H9N2-NA and NDV-F genes under control of MDV's own bi-directional promoter

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Zhang, Zhenjie ^a,b   Ma, Chengtai ^a,b   Zhao, Peng ^a,b   Duan, Luntao ^a,b   Chen, Wenqing ^a,b   Zhang, Fushou ^a,b   Cui, Zhizhong ^a,b  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

^b Sino German Cooperative Research Centre for Zoonosis of Animal Origin Shandong Province Key Laboratory of Animal Biotechnology and Disease Control and Prevention of Shandong Province Research Center for Animal Disease Control Engineering of Shandong Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HETERODIMER; MESSENGER RNA; PROTEIN PP24; PROTEIN PP38; SIALIDASE; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ARTICLE; CHICKEN; CONTROLLED STUDY; EMBRYO; EMBRYO FIBROBLAST; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; FUSION GENE; GENE ACTIVATION; GENE CASSETTE; GENE EXPRESSION; GENE INSERTION; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOME SIZE; HOMOLOGOUS RECOMBINATION; INFLUENZA VIRUS A H9N2; MARDIVIRUS; NEURAMINIDASE GENE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROMOTER REGION; QUALITATIVE ANALYSIS; TRANSGENICS; TRANSIENT EXPRESSION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS STRAIN; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CHICK EMBRYO; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, VIRAL; INFLUENZA A VIRUS, H9N2 SUBTYPE; MARDIVIRUS; MAREK DISEASE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; NEURAMINIDASE; NEWCASTLE DISEASE VIRUS; PROMOTER REGIONS, GENETIC; PROTEIN MULTIMERIZATION; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 84897133888     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090677     Document Type: Article

References (46)

1. McGeoch DJ, Dolan A, Ralph AC (2000) Toward a comprehensive phylogeny for mammalian and avian herpesviruses. Journal of Virology 74: 10401-10406.
2. Su S, Cui N, Cui ZZ, Zhao P, Li YP, et al. (2012) Complete Genome Sequence of a Recombinant Marek's Disease Virus Field Strain with One Reticuloendotheliosis Virus Long Terminal Repeat Insert. Journal of Virology 86(24): 13818.
3. Barlic-Maganja D, Grom J (2001) Highly sensitive one-tube RT-PCR and microplate hybridisation assay for the detection and for the discrimination of classical swine fever virus from other pestiviruses. Journal of virological methods 95: 101-110. (Pubitemid 32493841)
4. Bradley G, Hayashi M, Lancz G, Tanaka A, Nonoyama M (1989) Structure of the Marek's disease virus BamHI-H gene family: Genes of putative importance for tumor induction. Journal of Virology 63: 2534-2542. (Pubitemid 19137528)
5. Bradley G, Lancz G, Tanaka A, Nonoyama M (1989) Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H. Journal of Virology 63: 4129-4135. (Pubitemid 19229407)
6. Cui ZZ, Lee LF, Liu JL, Kung HJ (1991) Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. Journal of Virology 65: 6509-6515.
7. Cui ZZ, Qin AJ, Lee LF (1992) Expression and processing of Marek' s disease virus pp38 gene insert cells and immunological characteriation of the gene product. Proceedings of 19th World' s Poulty Congress: 123-126.
8. Ding JB, Cui ZZ, Jiang SJ, Sun AJ, Sun SH (2005) Study on the characterization of the bi-directional promoter between pp38 gene and 1.8kb mRNA transcripts of Marek's disease viruses. Acta Microbidogica Sinica 45(3): 363-367.
9. Ding JB, Cui ZZ, Jiang SJ, Reddy SJ (2006) The enhancement effect of pp38 gene product on the activity of its upstream bi-directional promoter in Marek's disease virus. Science in China: Series C Life Sciences 49: 1-10.
10. Ding JB, Cui ZZ, Lee LF (2007) Marek's disease virus unique genes pp38 and pp24 are essential for transactivating the bi-directional promoters for the 1.8-kb mRNA transcripts. Virus Genes 35(3): 643-650.
11. Taylor J, Edbauer C, Rey-Senelonge A, Bouquet JF, Norton E, et al. (1990) Newcastle disease virus fusion protein expressed in a fowl pox virus recombinant confers protection in chickens. Journal of Virology 64(4): 1441-1450. (Pubitemid 20104878)
12. Morgan RW, Gelb J, Schreurs CS, Lütticken D, Rosenberger JK, et al. (1992) Protection of chickens from Newcastle and Mark's disease with a recombinant herpserivus of turkey's vaccine expressing the Newcastl e disease virus fusion protein. Avian Dis 36: 858-870.
13. Webster RG, Kawaoka Y, Taylor J, Weinberg R, Paoletti E (1991) Efficacy of nucleo protein and haemagglutinin antigens expressed in fowl pox virus as vaccine for influenza in chickens. Vaccine 9: 303-308.
14. Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL (2000) Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with recombinant fowl pox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18: 1088-1095.
15. Ma MX, Jin NY, Wang ZG, Wang RL,Fei DL, et al. (2006) Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine 24(20): 4304-431.
16. Sonoda K, Sakaguchi M, Okamura H, Yokogawa K, Tokunaga E, et al. (2000) Development of an Effective Polyvalent Vaccine against both Marek's and Newcastle Diseases Based on Recombinant Marek's Disease Virus Type 1 in Commercial Chickens with Maternal Antibodies. Journal of Virology 74(7): 3217-3226. (Pubitemid 30143746)
17. Tsukamoto K, Kojima C, Komori Y, Tanimura N, Mase M, et al. (1999) Protection of Chickens against Very Virulent Infectious Bursal Disease Virus (IBDV) and Marek's Disease Virus (MDV) with a Recombinant MDV Expressing IBDV VP2. Virology 257: 352-362. (Pubitemid 29393403)
18. Sakaguchi M, Nakamura H, Sonoda K, Okamura H, Yokogawa K, et al. (1998) Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1. Vaccine 16(5): 472-479. (Pubitemid 28044164)
19. Petherbridge L, Brown AC, Baigent SJ, Howes K, Sacco MA, et al. (2004) Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromo-somes. J Virol 78: 13376-13380. (Pubitemid 39507844)
20. Baigent SJ, Petherbridge LJ, Smith LP, Zhao Y, Chesters PM, et al. (2006) Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J Gen Virol 87: 769-776.
21. Cui HY, Wang YF, Shi XM, Tong GZ, Lan DS, et al. (2008) Construction of Marek's disease virus serotype 814 strain as an infectioous bacterial artificial chromosome. Chinese journal of biotechnology 24: 569-575.
22. Sun AJ, Petherbridge LP, Zhao Y, Li YP, Cui ZZ, et al. (2009) A BAC clone of MDV strain GX0101 with REV-LTR integration retained its pathogenicity. Chinese Science Bulletin 54 (15): 2641-2647.
23. Li YP, Sun AJ, Su S, Zhao P, Cui ZZ, et al. (2011) Deletion of the Meq gene significantly decreases immunosuppression in chickens caused by pathogenic Marek's disease virus. Virology journal: 2-8.
24. Su S, Li YP, Sun AJ, Zhao P, Cui ZZ, et al. (2010) Protective immunity of a meqDdeleted Marek's disease virus against very virulent virus challenge in chickens. Acta Microbiologica Sinica 50(3): 380-386.
25. Reddy SM, Lupiani B, Gimeno IM, Silva RF, Lee LF, et al. (2002) Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc Natl Acad Sci USA 99(May (10)): 7054-7059.
26. Lee LF, Kreager KS, Arango J, Paraguassu A, Beckman B, et al. (2010) Comparative evaluation of vaccine dfficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens. Vaccine 28(5): 1294-1299.
27. Lee LF, Zhang HM, Heidari M, Lupiani B, Reddy SM (2011) Evaluation of factors affecting vaccine dfficacy of recombinant Marek's disease virus lacking the Meq oncogene in chickens. Avian Dis.55(2): 172-179.
28. Lee LF, Heidari M, Zhang HM, Lupiani B, Reddy SM, et al. (2012) Cell culture attenuation eliminates rMd5Meq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease. Vaccine 30(34): 5151-5158.
29. Zhang Z, Cui ZZ (2005) Isolation of recombinant field strains of Marek's disease virus integration with reticuloendotheliosis virus genome fragments. Sci. China C. Life Sci 48 (1): 81-88. (Pubitemid 44112684)
30. Sun SH, Cui ZZ (2007) Biological Identification of Newcastle Disease Viruses Isolated from Eggs of a Parent Breeder Farm. Acta Veterinaria et Zootechnica Sinica 38(7): 741-743.
31. Jiang SJ, Ding JB, Meng SS, Cui ZZ, Yang HC (2005) Co-expression and Construction of Eukaryote Plasmid of pp38 and pp24 of Marekcs Disease Virus.Virologica sinica 20(4): 404-407.
32. Morgan RW, Cantello JL, McDermott CH (1990) Transfection of chicken embryo fibroblasts with Marek's disease virus DNA. Avian Diseases 34: 345-351.
33. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97 (12): 6640-6645. (Pubitemid 30412767)
34. Muyrers JP, Zhang Y, Testa G, Stewart AF (1999) Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 27 (6): 1555-1557. (Pubitemid 29206301)
35. Narayanan K, Williamson R, Zhang Y, Stewart AF, Ioannou PA (1999) Efficient and precise engineering of a 200 kb beta-globin human bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther 6: 442-447. (Pubitemid 29132346)
36. Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG, et al. (2000) An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A 97: 5978-5983. (Pubitemid 30367509)
37. Sun AJ, Xu XY, Lawrence PB, Zhao YG, Cui ZZ (2010) Functional evaluation of the role of reticuloendotheliosis virus long terminal repeat (LTR) integrated into the genome of a field strain of Marek's disease virus. Virology 397: 270-276.
38. Cui HY, Wang YF, Shi XM, An TQ, Tong GZ, et al. (2009) Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterizationof protection induced in chickens. Journal of Virological Methods 156: 66-72.
39. Schumacher D, Tischer BK, Fuchs W, Osterrieder N (2000) Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. Journal of Virology 74: 11088-11098. (Pubitemid 32223974)
40. Li Y, Reddy K, Reid SM, Cox WJ, Brown IH, et al. (2011) Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease. Vaccine 29: 8257-8266.
41. Ding JB, Cui ZZ, Jiang SJ, Li YP (2008) The structure of unique genes pp38 and pp24 and the effect on the activity of its upstream bi-directional promoters in Marek's disease virus. Science in China: Series C Life Sciences 38: 760-765.
42. Shigekane H, Kawaguchi Y, Shirakata M, Sakaguchi M, Hirai K (1999) The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers. Archives of Virology 144: 1893-1907.
43. Ding JB, Cui ZZ, Lee LF, Cui XP, Reddy SM (2006) The role of pp38 in regulation of Marek's disease virus bi-directional promoter between pp38 and 1.8-kb mRNA. Virus Genes 32(2): 193-201.
44. Gimeno IM, Witter RL, Hunt HD, Reddy SM, Lee LF, et al. (2005) The pp38 gene of Marek's disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV. Journal of Virology, 79(7): 4545-4549. (Pubitemid 40388394)
45. Su S (2013) Comparisons of Biological Characteristic between Recombinant Marek's disease virus and its Mutant Strains. Tai'an: Shandong Agricultural university.
46. Cui HY, Gao HB, Cui XL, Zhao Y, Wang YF, et al. (2013) Avirulent Marek's Disease Virus Type 1 Strain 814 Vectored Vaccine Expressing Avian Influenza (AI) Virus H5 Haemagglutinin Induced Better Protection Than Turkey Herpesvirus Vectored AI Vaccine. PLoS ONE 8(1): e53340.